US Stock MarketDetailed Quotes
FBIO Fortress Biotech
- 1.7100
- -0.0100-0.58%
Close Nov 8 16:00 ET
- 1.6605
- -0.0495-2.89%
Post 20:01 ET
47.13MMarket Cap-553P/E (TTM)
1.7600High1.6600Low313.58KVolume1.7100Open1.7200Pre Close534.88KTurnover1.64%Turnover RatioLossP/E (Static)27.56MShares4.430052wk High2.64P/B32.69MFloat Cap1.280052wk Low--Dividend TTM19.12MShs Float190.5000Historical High--Div YieldTTM5.81%Amplitude1.2400Historical Low1.7050Avg Price1Lot Size
Fortress Biotech Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -14.32%14.9M | 4.84%13.03M | 11.58%84.51M | 21.59%19.95M | 110.26%34.75M | -7.94%17.39M | -48.05%12.43M | 10.11%75.74M | -10.24%16.4M | -21.61%16.53M |
| Operating revenue | -13.27%14.9M | 5.24%13.03M | -11.05%64.99M | 21.93%19.95M | -5.85%15.49M | -8.79%17.18M | -42.21%12.38M | 6.22%73.07M | -10.49%16.36M | -21.96%16.46M |
| Cost of revenue | -15.78%6.54M | 5.69%6.82M | -13.37%26.66M | -22.07%6.02M | -10.97%6.43M | 1.76%7.77M | -21.38%6.45M | -4.08%30.78M | -18.97%7.72M | -35.34%7.22M |
| Gross profit | -13.14%8.36M | 3.91%6.21M | 28.65%57.85M | 60.38%13.93M | 204.32%28.32M | -14.52%9.62M | -61.96%5.98M | 22.51%44.97M | -0.74%8.69M | -6.16%9.31M |
| Operating expense | -40.80%33.49M | -34.03%42.78M | -19.45%200.2M | -42.06%36.69M | -29.91%42.08M | -9.00%56.58M | 2.94%64.85M | 15.22%248.53M | -10.50%63.32M | 19.36%60.04M |
| Selling and administrative expenses | -14.80%20.82M | -29.20%17.94M | -17.19%94.12M | -19.81%22.61M | -27.89%21.73M | -15.87%24.44M | -3.54%25.34M | 30.88%113.66M | 1.81%28.2M | 35.63%30.14M |
| Research and development costs | -60.58%12.67M | -37.13%24.84M | -21.36%106.07M | -59.92%14.08M | -31.95%20.35M | -2.99%32.14M | 7.58%39.51M | 4.66%134.88M | -18.43%35.12M | 6.49%29.9M |
| Operating profit | 46.47%-25.14M | 37.88%-36.57M | 30.08%-142.34M | 58.35%-22.76M | 72.88%-13.76M | 7.78%-46.96M | -24.53%-58.87M | -13.72%-203.56M | 11.88%-54.63M | -25.63%-50.73M |
| Net non-operating interest income expense | 75.69%-1.39M | 45.74%-1.77M | -0.56%-12.31M | 66.68%-1.35M | 33.19%-1.99M | -90.08%-5.71M | -47.64%-3.26M | 16.47%-12.24M | 29.68%-4.06M | 31.03%-2.97M |
| Non-operating interest income | 2.66%734K | -19.59%833K | 114.81%3M | 2.91%707K | 30.55%547K | 376.67%715K | 629.58%1.04M | 115.41%1.4M | 377.08%687K | 217.42%419K |
| Non-operating interest expense | -71.34%1.49M | -39.97%1.99M | 14.38%11.92M | -49.83%1.52M | -33.89%1.88M | 100.31%5.2M | 69.30%3.32M | -8.57%10.42M | -16.67%3.02M | -23.76%2.84M |
| Total other finance cost | -48.41%631K | -37.60%609K | 5.43%3.4M | -68.46%544K | 18.59%657K | 119.57%1.22M | 150.90%976K | -17.60%3.23M | -24.71%1.73M | -23.06%554K |
| Other net income (expense) | 65.35%-2.3M | -109.85%-688K | -56.44%1.02M | -365.04%-4.5M | 696.60%5.16M | -6.63M | 6.98M | -92.00%2.34M | 744.87%1.7M | 155.57%648K |
| Gain on sale of security | 113.67%70K | -109.99%-667K | 291.85%4.42M | ---6.28M | --4.54M | ---512K | --6.68M | -97.09%1.13M | ---- | ---- |
| Special income (charges) | 59.32%-2.65M | ---- | ---- | ---- | --0 | ---6.51M | ---- | ---- | ---- | --0 |
| -Less:Impairment of capital assets | -15.72%2.65M | ---- | ---- | ---- | --0 | --3.14M | ---- | ---- | ---- | --0 |
| -Gain on sale of business | --0 | ---- | ---- | ---- | ---- | ---3.37M | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -28.61%282K | -106.91%-21K | -380.08%-3.4M | -338.80%-1.35M | -4.32%620K | --395K | --304K | --1.22M | --567K | --648K |
| Income before tax | 51.39%-28.82M | 29.24%-39.02M | 28.03%-153.63M | 49.81%-28.61M | 80.05%-10.58M | -9.96%-59.3M | -11.45%-55.15M | -29.88%-213.46M | 16.23%-57M | -15.70%-53.06M |
| Income tax | 16.04%521K | -15.59%379K | 141K | -5.07%449K | 449K | 0 | ||||
| Net income | 51.39%-28.82M | 29.24%-39.02M | 27.94%-154.15M | 49.54%-28.98M | 79.79%-10.72M | -9.96%-59.3M | -11.45%-55.15M | -29.78%-213.91M | 16.15%-57.45M | -15.70%-53.06M |
| Net income continuous Operations | 51.39%-28.82M | 29.24%-39.02M | 27.94%-154.15M | 49.54%-28.98M | 79.79%-10.72M | -9.96%-59.3M | -11.45%-55.15M | -29.78%-213.91M | 16.15%-57.45M | -15.70%-53.06M |
| Minority interest income | 48.22%-17.88M | 29.76%-23.61M | 26.56%-93.52M | 35.39%-19.71M | 81.41%-5.68M | -5.99%-34.53M | 0.33%-33.61M | -27.18%-127.34M | 17.45%-30.5M | -21.81%-30.55M |
| Net income attributable to the parent company | 55.81%-10.95M | 28.42%-15.42M | 29.96%-60.64M | 65.57%-9.28M | 77.59%-5.05M | -16.01%-24.78M | -36.66%-21.54M | -33.80%-86.58M | 14.63%-26.95M | -8.32%-22.51M |
| Preferred stock dividends | 0.00%2M | -2M | 0.00%8.03M | 0.00%2.01M | 0.00%2.01M | -0.40%2M | 8.03M | 2.01M | 2.01M | |
| Other preferred stock dividends | 300.00%400K | -300K | 100K | |||||||
| Net income attributable to common stockholders | 50.44%-13.34M | 24.69%-17.73M | 27.42%-68.67M | 61.02%-11.29M | 71.23%-7.05M | -15.21%-26.92M | -49.40%-23.55M | -46.22%-94.61M | 8.27%-28.96M | -17.99%-24.52M |
| Basic earnings per share | -200.00%-10.95 | 70.32%-1.03 | 46.96%-8.47 | 89.07%-0.526 | 77.13%-0.9405 | 6.41%-3.65 | -28.52%-3.47 | -34.77%-15.97 | 15.54%-4.8144 | -5.44%-4.1121 |
| Diluted earnings per share | -200.00%-10.95 | 70.32%-1.03 | 46.96%-8.47 | 89.07%-0.526 | 77.13%-0.9405 | 6.41%-3.65 | -28.52%-3.47 | -34.77%-15.97 | 15.54%-4.8144 | -5.44%-4.1121 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data